Research Topics
| M E KuehneSummaryAffiliation: University of Vermont Country: USA Publications
| Collaborators
|
Detail Information
Publications
Biogenetic syntheses of kopsijasminilam and deoxykopsijasminilamM E Kuehne
Department of Chemistry, University of Vermont, Burlington 05405, USA
J Org Chem 65:6434-40. 2000..Formation of a carbamate, introduction of a second double bond at C-16, and conjugate reductive hydroxylation at C-20, or hydrogenation, gave the title products...
New ferrocenyl chiral auxiliary substituents for amines: applications to syntheses of mossambine and vinblastineM E Kuehne
Department of Chemistry, University of Vermont, Burlington, VT 05405, USA
J Org Chem 66:1560-6. 2001..Thus, key intermediates leading to mossambine and vinblastine could be synthesized with high enantioselectivity. The enantioselectivity greatly exceeds that found with other chiral N-auxiliaries developed in our studies...
Syntheses of 5a'-homo-vinblastine and congeners designed to establish structural determinants for isolation of atropisomersM E Kuehne
Department of Chemistry, University of Vermont, Burlington, 05405, USA
J Org Chem 66:5303-16. 2001....
The syntheses of 16a'-homo-leurosidine and 16a'-homo-vinblastine. Generation of atropisomersM E Kuehne
Department of Chemistry, University of Vermont, Burlington, 05405, USA
J Org Chem 66:5317-28. 2001..The synthesis was achieved through a stereoselective inversion of the tertiary hydroxyl function in the enantioselectively generated C-20' progenitor 39...
Synthesis and biological evaluation of 18-methoxycoronaridine congeners. Potential antiaddiction agentsMartin E Kuehne
Department of Chemistry, University of Vermont, Burlington, Vermont 05405, USA
J Med Chem 46:2716-30. 2003..The opioid activities were relatively low, and the alpha3beta4 nicotinic acetylcholine receptor activities were found to correlate with in vivo antiaddictive activities...
A biomimetic synthesis of the pauciflorine A and B skeletonM E Kuehne
Department of Chemistry, University of Vermont, Burlington 05405, USA
Org Lett 1:1749-50. 1999..formula: see text] Racemic minovincine (3), following cyclization, reduction, O-tosylation, fragmentation, and carbamate formation, provided the deoxypauciflorine 12...
Novel iboga alkaloid congeners block nicotinic receptors and reduce drug self-administrationChristopher J Pace
Center for Neuropharmacology and Neuroscience, The Albany Medical College, MC-136, 47 New Scotland Avenue, Albany, NY 12208, USA
Eur J Pharmacol 492:159-67. 2004..These compounds may constitute a new class of synthetic agents that act via the nicotinic alpha3beta4 mechanism to combat addiction...
Syntheses and biological evaluation of vinblastine congenersMartin E Kuehne
Department of Chemistry, University of Vermont, Burlington, VT 05405, USA
Org Biomol Chem 1:2120-36. 2003..An ID50 range of >10(7) M concentrations was found for L1210 inhibition by these compounds, with the most active 1000x as potent as vinblastine...
In vitro activities of iboga alkaloid congeners coronaridine and 18-methoxycoronaridine against Leishmania amazonensisJan Carlo Delorenzi
Departamento de Imunologia, Instituto de Microbiologia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
Antimicrob Agents Chemother 46:2111-5. 2002..Despite their potent leishmanicide effect, both alkaloids were neither toxic to murine macrophages nor did they modulate their oxidative or cytokine production responses...
Metabolism of 18-methoxycoronaridine, an ibogaine analog, to 18-hydroxycoronaridine by genetically variable CYP2C19Wenjiang Zhang
Center for Addiction and Mental Health, University of Toronto, Toronto, Canada
Drug Metab Dispos 30:663-9. 2002..The apparent selectivity of this pathway for CYP2C19 suggests 18-MC as a potentially useful probe of CYP2C19 activity in vitro and in vivo...
Anti-HIV-1 activity of the Iboga alkaloid congener 18-methoxycoronaridineEdinete M Silva
, , Salvador, BA, Brazil
Planta Med 70:808-12. 2004..6 and 34.5. 18-MC moderately inhibits the HIV-1 enzyme reverse transcriptase (IC (50) = 69.4 microM), which at least partially explains its antiretroviral activity...
